NTRK3 and breast carcinoma: Relative to those in normal or nontransformed cells (HMLE, MCF7, or MCF10A), the levels of IL-6 were dramatically increased in highly metastatic breast cancer cells (MDA-MB-231, Hs578T, and SUM149), which highly express TrkC (Figure S1a and 4b).